New Delhi: Ajanta Pharma today reported a 43.39 per cent rise in consolidated net profit to Rs 106.31 crore for the quarter ended March 31, mainly on account of robust sales.
The company had posted a net profit of Rs 74.14 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a filing to BSE.
Consolidated total income from the operations of the company also rose to Rs 425.73 crore for the quarter under review as against Rs 372.09 crore for the year-ago period.
“Despite challenges of foreign currency volatility and scarcity in the emerging markets, we have posted overall satisfactory growth during the quarter,” Ajanta Pharma MD Yogesh Agrawal said.
The net profit for the fiscal year ended March 2016 also rose to Rs 401.41 crore as against Rs 309.86 crore for the same period a year ago.
Consolidated total income from operations of the company also rose to Rs 1,727.53 crore for the last fiscal. It was Rs 1,473.55 crore in 2014-15.
Shares of Ajanta Pharma were trading at Rs 1,492.70 per scrip in the afternoon trade on BSE, down 2.77 per cent from its previous close.